24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Entera Bio
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:54
From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey
11:21
Mixpanel is here to help gaming companies democratize their data
09:10
Here’s how gaming brands can reach wider audiences: “Never make assumptions!”
09:01
Israel’s gaming sector is 2% of its GDP - so why is the government ignoring it?
More stories
Buzz
Most popular
Daily
Weekly
1
Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?
2
Kaltura CEO: "Just like a missile hit our office, a missile hit us with the IPO"
3
Windward acquired for $270M by FTV Capital, doubling its IPO valuation
4
8 Israeli cyber companies travel to the UK for collaboration opportunities
5
$41B in exits: Why Israeli cyber startups are a global powerhouse
More news
Entera Bio
3 stories about Entera Bio
Fourth Time’s the Charm for Entera Bio IPO
01.07.18
|
Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
Entera Bio Files for Nasdaq IPO
12.11.17
|
Lilach Baumer
The clinical stage company develops treatments mostly for osteoporosis and bone disorders
IPO Hopeful Entera Bio Moves to Better Position
13.09.17
|
Dror Reich
Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism
Please ensure Javascript is enabled for purposes of
website accessibility